+ Follow ASIAN PACIFIC ASSOCIATION Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1258907
[Title] => Phl to host AsPac gab on liver cancer
[Summary] => The Philippines is hosting the 3rd Asian Pacific Association for the Study of the Liver Conference in Cebu City from Nov. 21 to 23, boosting efforts to address liver cancer which afflicts 600,000 individuals worldwide every year.
[DatePublished] => 2013-11-21 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 952434
[Title] => Pushing for hepatitis awareness
[Summary] => The National Viral Hepatitis Task Force (NVHTF), the Viral Hepatitis Foundation (VHF), and the Hepatology Society of the Philippines (HSP) came together recently for a Hepatitis B consultative meeting.
[DatePublished] => 2013-06-11 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[2] => Array
(
[ArticleID] => 391654
[Title] => Increasing awareness to combat hepatitis B
[Summary] =>
Understanding the problem is key to finding solutions. The 3rd Hepatitis B Summit held in Makati City recently was noteworthy because it enabled medical practitioners, healthcare providers, and the average laypersons to understand hepatitis B’s effects and the repercussions of the disease. The forum clarified various aspects about hepatitis B infection and did much to increase awareness about the need for vaccination against the virus.
[DatePublished] => 2007-03-27 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1422176
[AuthorName] => Joy Angelica Subido
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[3] => Array
(
[ArticleID] => 341922
[Title] => 2nd leg of Hepa B summit set to open here today
[Summary] => The second leg of the Hepatitis B Summit will be held here today at the Waterfront Cebu City Hotel, with delegates from the professional medical community arriving to meet with Cebu counterparts.
The summit is part of an ongoing advocacy that endeavors to build awareness not only among chronic Hepatitis B patients, but within the medical community as well.
[DatePublished] => 2006-06-14 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Cebu News
[SectionUrl] => cebu-news
[URL] =>
)
[4] => Array
(
[ArticleID] => 336264
[Title] => Liver health awareness summit set here in June
[Summary] => Delegates from the professional medical community are set to arrive in Cebu to meet with their counterparts in a liver health awareness summit that will be held at the Waterfront Hotel, Lahug next month.
The summit is part of an ongoing advocacy that endeavors to build awareness not only among Chronic Hepatitis B patients, but also within the medical community as well.
[DatePublished] => 2006-05-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Cebu News
[SectionUrl] => cebu-news
[URL] =>
)
[5] => Array
(
[ArticleID] => 323938
[Title] => Hepa B summit addresses key issues
[Summary] => The countrys First Hepatitis B Summit concluded with key recommendations from various medical groups for the control of hepatitis B.
Three of the most important issues addressed during the summit revolved around prevention through vaccination, disease management, and employability of hepatitis B patients.
Hepatitis B, considered by the World Health Organization as the most common serious liver infection in the world, can infect any person at any age. It is associated with liver cancer, which is one of the most common in Asia.
[DatePublished] => 2006-03-02 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 320795
[Title] => How chronic is hepatitis B in RP?
[Summary] => Hepatitis B is recognized by the World Health Organization as the most common serious liver infection in the world. The disease is so serious that lack of treatment may lead to cirrhosis of the liver, liver cancer, liver failure, and eventually death.
The problem, however, is compounded by the fact that very few hepatitis B patients are aware that they are infected.
A study made by a research group called Synovate Healthcare revealed that most patients suffering from chronic hepatitis B (CHB) in Asia initially did not suspect that they were infected.
[DatePublished] => 2006-02-09 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 274759
[Title] => New hepa B treatment cited
[Summary] => At the recent 14th biennial conference of the Asian Pacific Association for the Study of the Liver, a new hepatitis B treatment option was cited.
Peginterferon alfa 2-a has been shown to treat both HbeAG-positive and HbeAG-negative chronic hepatitis B, thus removing the need for daily and potentially life-long therapy for the disease.
The studies presented during the conference showed that peginterferon alfa 2-a is superior to lamivudine, the most commonly prescribed medication for hepatitis B.
[DatePublished] => 2005-04-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
ASIAN PACIFIC ASSOCIATION
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1258907
[Title] => Phl to host AsPac gab on liver cancer
[Summary] => The Philippines is hosting the 3rd Asian Pacific Association for the Study of the Liver Conference in Cebu City from Nov. 21 to 23, boosting efforts to address liver cancer which afflicts 600,000 individuals worldwide every year.
[DatePublished] => 2013-11-21 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 952434
[Title] => Pushing for hepatitis awareness
[Summary] => The National Viral Hepatitis Task Force (NVHTF), the Viral Hepatitis Foundation (VHF), and the Hepatology Society of the Philippines (HSP) came together recently for a Hepatitis B consultative meeting.
[DatePublished] => 2013-06-11 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[2] => Array
(
[ArticleID] => 391654
[Title] => Increasing awareness to combat hepatitis B
[Summary] =>
Understanding the problem is key to finding solutions. The 3rd Hepatitis B Summit held in Makati City recently was noteworthy because it enabled medical practitioners, healthcare providers, and the average laypersons to understand hepatitis B’s effects and the repercussions of the disease. The forum clarified various aspects about hepatitis B infection and did much to increase awareness about the need for vaccination against the virus.
[DatePublished] => 2007-03-27 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1422176
[AuthorName] => Joy Angelica Subido
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[3] => Array
(
[ArticleID] => 341922
[Title] => 2nd leg of Hepa B summit set to open here today
[Summary] => The second leg of the Hepatitis B Summit will be held here today at the Waterfront Cebu City Hotel, with delegates from the professional medical community arriving to meet with Cebu counterparts.
The summit is part of an ongoing advocacy that endeavors to build awareness not only among chronic Hepatitis B patients, but within the medical community as well.
[DatePublished] => 2006-06-14 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Cebu News
[SectionUrl] => cebu-news
[URL] =>
)
[4] => Array
(
[ArticleID] => 336264
[Title] => Liver health awareness summit set here in June
[Summary] => Delegates from the professional medical community are set to arrive in Cebu to meet with their counterparts in a liver health awareness summit that will be held at the Waterfront Hotel, Lahug next month.
The summit is part of an ongoing advocacy that endeavors to build awareness not only among Chronic Hepatitis B patients, but also within the medical community as well.
[DatePublished] => 2006-05-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Cebu News
[SectionUrl] => cebu-news
[URL] =>
)
[5] => Array
(
[ArticleID] => 323938
[Title] => Hepa B summit addresses key issues
[Summary] => The countrys First Hepatitis B Summit concluded with key recommendations from various medical groups for the control of hepatitis B.
Three of the most important issues addressed during the summit revolved around prevention through vaccination, disease management, and employability of hepatitis B patients.
Hepatitis B, considered by the World Health Organization as the most common serious liver infection in the world, can infect any person at any age. It is associated with liver cancer, which is one of the most common in Asia.
[DatePublished] => 2006-03-02 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 320795
[Title] => How chronic is hepatitis B in RP?
[Summary] => Hepatitis B is recognized by the World Health Organization as the most common serious liver infection in the world. The disease is so serious that lack of treatment may lead to cirrhosis of the liver, liver cancer, liver failure, and eventually death.
The problem, however, is compounded by the fact that very few hepatitis B patients are aware that they are infected.
A study made by a research group called Synovate Healthcare revealed that most patients suffering from chronic hepatitis B (CHB) in Asia initially did not suspect that they were infected.
[DatePublished] => 2006-02-09 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 274759
[Title] => New hepa B treatment cited
[Summary] => At the recent 14th biennial conference of the Asian Pacific Association for the Study of the Liver, a new hepatitis B treatment option was cited.
Peginterferon alfa 2-a has been shown to treat both HbeAG-positive and HbeAG-negative chronic hepatitis B, thus removing the need for daily and potentially life-long therapy for the disease.
The studies presented during the conference showed that peginterferon alfa 2-a is superior to lamivudine, the most commonly prescribed medication for hepatitis B.
[DatePublished] => 2005-04-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
February 9, 2006 - 12:00am